Citations (240)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Shereen M. Elkiki, Heba H. Mansour, Lobna M. Anis, Hanan M. Gabr & Mona M. Kamal. (2021) Evaluation of aromatase inhibitor on radiation induced pulmonary fibrosis via TGF- β/Smad 3 and TGF- β/PDGF pathways in rats. Toxicology Mechanisms and Methods 31:7, pages 538-545.
Read now
Read now
Toyoshi Yanagihara, Sy Giin Chong, Megan Vierhout, Jeremy A. Hirota, Kjetil Ask & Martin Kolb. (2020) Current models of pulmonary fibrosis for future drug discovery efforts. Expert Opinion on Drug Discovery 15:8, pages 931-941.
Read now
Read now
Kekoa Taparra, Heshan Liu, Mei-Yin Polley, Kay Ristow, Thomas M. Habermann & Stephen M. Ansell. (2020) Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era. Leukemia & Lymphoma 61:2, pages 298-308.
Read now
Read now
Maja D. Andersen, Peter Kamper, Alexander d’Amore, Michael Clausen, Hans Bentzen & Francesco d'Amore. (2019) The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor. Leukemia & Lymphoma 60:4, pages 927-933.
Read now
Read now
Heena Mehta, Philippe-Olivier Goulet, Vinh Nguyen, Gemma Pérez, Martial Koenig, Jean-Luc Senécal & Marika Sarfati. (2016) Topoisomerase I peptide-loaded dendritic cells induce autoantibody response as well as skin and lung fibrosis. Autoimmunity 49:8, pages 503-513.
Read now
Read now
Mário Santos, Tiago Henriques-Coelho & Adelino Leite-Moreira. (2010) Immunomodulatory role of thymulin in lung diseases. Expert Opinion on Therapeutic Targets 14:2, pages 131-141.
Read now
Read now
Fiorella Calabrese, Cinzia Giacometti, Francesca Lunardi & Marialuisa Valente. (2008) Morphological and molecular markers in idiopathic pulmonary fibrosis. Expert Review of Respiratory Medicine 2:4, pages 505-520.
Read now
Read now
Deborah E. Sullivan, MaryBeth Ferris, Derek Pociask & Arnold R. Brody. (2008) The Latent Form of TGFβ1 is Induced by TNFα Through an ERK Specific Pathway and is Activated by Asbestos-Derived Reactive Oxygen Species In Vitro and In Vivo. Journal of Immunotoxicology 5:2, pages 145-149.
Read now
Read now
Hiroshi Miyazawa, Yuichi Takiguchi, Kenzo Hiroshima, Katsushi Kurosu, Yuji Tada, Yasunori Kasahara, Seiichiro Sakao, Nobuhiro Tanabe, Koichiro Tatsumi & Takayuki Kuriyama. (2008) PULMONARY AND SYSTEMIC TOXICITY OF BLEOMYCIN ON SEVERE COMBINED IMMUNE DEFICIENCY MICE. Experimental Lung Research 34:1, pages 1-17.
Read now
Read now
Anna Wędrychowicz, Jolanta Goździk, Aleksandra Krasowska-Kwiecień, Ewa Kacińka, Oktawiusz Wiecha, Krystyna Kubiczek & Mariusz Z. Ratajczak$suffix/text()$suffix/text(). (2006) MANIFESTATION OF TOXOCARIASIS IN CHILDREN WITH NEUROBLASTOMA TREATED WITH AUTOLOGOUS HEMATOPOIETIC TRANSPLANTS. Pediatric Hematology and Oncology 23:5, pages 369-379.
Read now
Read now
Thomas H. Thatcher, Patricia J. Sime & Richard K. Barth. (2005) SENSITIVITY TO BLEOMYCIN-INDUCED LUNG INJURY IS NOT MODERATED BY AN ANTIGEN-LIMITED T-CELL REPERTOIRE. Experimental Lung Research 31:7, pages 685-700.
Read now
Read now
Koji Kawai & Hideyuki Akaza. (2003) Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer. Expert Opinion on Drug Safety 2:6, pages 587-596.
Read now
Read now
Peter M Krein, Yong Huang & Brent W Winston. (2001) Growth factor regulation and manipulation in wound repair: to scar or not to scar, that is the question. Expert Opinion on Therapeutic Patents 11:7, pages 1065-1079.
Read now
Read now
Luis A. Ortiz, Joseph Lasky, Raymond F. Hamilton, Andrij Holian, Gary W. Hoyle, William Banks, Jacques J. Peschon, Arnold R. Brody, Giuseppe Lungarella & Mitchell Friedman. (1998) Expression of TNF and the Necessity of TNF Receptors in Bleomycin-Induced Lung Injury in Mice. Experimental Lung Research 24:6, pages 721-743.
Read now
Read now
PaulG. Reinhart & C. Gary Gairola. (1997) AMIODARONE-INDUCED PULMONARY TOXICITY IN FISCHER RATS: RELEASE OF TUMOR NECROSIS FACTOR ALPHA AND TRANSFORMING GROWTH FACTOR BETA BY PULMONARY ALVEOLAR MACROPHAGES. Journal of Toxicology and Environmental Health 52:4, pages 353-365.
Read now
Read now
Jason Temelkovski, Rakesh K. Kumar & Sonia E. Maronese. (1997) Enhanced Production of an Egf-Like Growth Factor by Parenchymal Macrophages Following Bleomycin-Induced Pulmonary Injury. Experimental Lung Research 23:5, pages 377-391.
Read now
Read now
Rakesh K. Kumar & Athol W.J. Lykke. (1995) Messages and handshakes: Cellular interactions in pulmonary fibrosis. Pathology 27:1, pages 18-26.
Read now
Read now
Articles from other publishers (223)
Karina Smidt Simon, Luísa Coutinho Coelho, Paulo Henrique de Holanda VelosoJr.Jr., Cesar Augusto Melo-Silva, José Athayde Vasconcelos Morais, João Paulo Figueiró Longo, Florencio Figueiredo, Leonora Viana, Ildinete Silva Pereira, Veronica Moreira Amado, Marcia Renata Mortari & Anamelia Lorenzetti Bocca. (2023) Innovative Pre-Clinical Data Using Peptides to Intervene in the Evolution of Pulmonary Fibrosis. International Journal of Molecular Sciences 24:13, pages 11049.
Crossref
Crossref
Hira Shaikh, Zulfa Omer, Roman A. Jandarov, Morgan P. McBee, Jennifer Scheler, Bruce Mahoney & Tahir Latif. (2023) FDG PET/CT as a Tool for Early Detection of Bleomycin-Induced Pulmonary Toxicity. Lymphatics 1:1, pages 45-54.
Crossref
Crossref
Xi Yang, Xue-Jun Huang, Zhang Chen, Ai-Li Xu, Hua Zhou, Xiao-Li Bi, Pei-Yu Yan & Ying Xie. (2023) A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin. Heliyon 9:3, pages e13598.
Crossref
Crossref
Haibo Hu, Fengchan Wang, Ping Han, Peng Li, Kun Wang, Huan Song, Guojing Zhao, Yue Li, Xuechao Lu, Weihong Tao & Huantian Cui. (2023) Bu-Fei-Huo-Xue capsule alleviates bleomycin-induced pulmonary fibrosis in mice through modulating gut microbiota. Frontiers in Pharmacology 14.
Crossref
Crossref
Zhihou GuoYaping ZhangFurong Yan. (2022) Potential of Mesenchymal Stem Cell-Based Therapies for Pulmonary Fibrosis. DNA and Cell Biology 41:11, pages 951-965.
Crossref
Crossref
Kleanthis Fytianos, Ronja Schliep, Sofia Mykoniati, Petra Khan, Katrin E. Hostettler, Michael Tamm, Amiq Gazdhar, Lars Knudsen & Thomas Geiser. (2022) Anti-Fibrotic Effect of SDF-1β Overexpression in Bleomycin-Injured Rat Lung. Pharmaceutics 14:9, pages 1803.
Crossref
Crossref
Kyunghwa Kim, Dasom Shin, Gaheon Lee & Hyunsu Bae. (2022) Loss of SP-A in the Lung Exacerbates Pulmonary Fibrosis. International Journal of Molecular Sciences 23:10, pages 5292.
Crossref
Crossref
Carolina Esquer, Oscar Echeagaray, Fareheh Firouzi, Clarissa Savko, Grant Shain, Pria Bose, Abigail Rieder, Sophie Rokaw, Andrea Witon-Paulo, Natalie Gude & Mark A Sussman. (2021) Fundamentals of vaping-associated pulmonary injury leading to severe respiratory distress. Life Science Alliance 5:2, pages e202101246.
Crossref
Crossref
Jie Jiao, Li Li, Wu Yao, Weidong Qin, Changfu Hao & Lingeng Lu. (2021) Influence of Silica Exposure for Lung Silicosis Rat. Disease Markers 2021, pages 1-9.
Crossref
Crossref
Yaniv Tomer, Jennifer Wambach, Lars Knudsen, Ming Zhao, Luis R. Rodriguez, Aditi Murthy, Frances V. White, Alessandro Venosa, Jeremy Katzen, Matthias Ochs, Aaron Hamvas, Michael F. Beers & Surafel Mulugeta. (2021)
The common ABCA3
E292V
variant disrupts AT2 cell quality control and increases susceptibility to lung injury and aberrant remodeling
. American Journal of Physiology-Lung Cellular and Molecular Physiology 321:2, pages L291-L307.
Crossref
Crossref
Ahmed Fawzy Eleraky, Gouda Kamel Helal, Mohamed F. Elshafie & Raed S. Ismail. (2021) Concomitant inhibition of hedgehog signalling and activation of retinoid receptors abolishes bleomycin‐induced lung fibrosis. Clinical and Experimental Pharmacology and Physiology 48:7, pages 1024-1040.
Crossref
Crossref
Zhiwei Xu, Xianli Yuan, Qiaoyan Gao, Yan Li & Mingcai Li. (2020) Interleukin-38 overexpression prevents bleomycin-induced mouse pulmonary fibrosis. Naunyn-Schmiedeberg's Archives of Pharmacology 394:2, pages 391-399.
Crossref
Crossref
Ali Hosseini-Sharifabad, Hassan Sadraei, Mohammad Hashemnia, Seyed Ebrahim Sajjadi & Zahra Mirdamadi. (2021)
Effect of hydroalcoholic and aqueous extracts of
Dracocephalum kotschyi
on bleomycin induced pulmonary fibrosis
. Journal of Herbmed Pharmacology 10:2, pages 209-217.
Crossref
Crossref
Pooya Torkian, Jianjun Li, John A. Kaufman & Younes Jahangiri. (2020) Effectiveness of Transarterial Embolization in Treatment of Symptomatic Hepatic Hemangiomas: Systematic Review and Meta-analysis. CardioVascular and Interventional Radiology 44:1, pages 80-91.
Crossref
Crossref
Haobo Lin, Chaochen Wu, Fu Zhu, Guangfeng Zhang, Yuesheng Xie, Yang Cui, Guangfu Dong & Xiao Zhang. (2020) Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast–to-myofibroblast transition. Advances in Medical Sciences 65:2, pages 338-347.
Crossref
Crossref
Pradnya D. Patil & Tanmay S. Panchabhai. 2020. Handbook of Cancer Treatment-Related Symptons and Toxicities. Handbook of Cancer Treatment-Related Symptons and Toxicities
61
72
.
Eleanor B. Reed, Shawn Ard, Jennifer La, Chan Young Park, Laura Culligan, Jeffrey J. Fredberg, Larisa V. Smolyaninova, Sergei N. Orlov, Bohao Chen, Robert Guzy, Gökhan M. Mutlu & Nickolai O. Dulin. (2019) Anti-fibrotic effects of tannic acid through regulation of a sustained TGF-beta receptor signaling. Respiratory Research 20:1.
Crossref
Crossref
Henrique Bregolin Dias, Jarbas Rodrigues de Oliveira, Márcio Vinícius Fagundes Donadio & Shioko Kimura. (2019) Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts. PLOS ONE 14:9, pages e0222202.
Crossref
Crossref
Nickolai O. Dulin, Larisa V. Smolyaninova & Sergei N. Orlov. 2019. Membrane Transporters in the Pathogenesis of Cardiovascular and Lung Disorders. Membrane Transporters in the Pathogenesis of Cardiovascular and Lung Disorders
15
43
.
Marianna M. Henry & Terry L. Noah. 2019. Kendig's Disorders of the Respiratory Tract in Children. Kendig's Disorders of the Respiratory Tract in Children
876
885.e6
.
Kyung Hwa Kim, Sujin Lee, Hyunji Lee, Dasom Shin, Daeun Min, Miran Kim, Byeol Ryu, Hyeon Woo Kim & Hyunsu Bae. (2018) A standardized herbal extract PM014 ameliorates pulmonary fibrosis by suppressing the TGF-β1 pathway. Scientific Reports 8:1.
Crossref
Crossref
Aastha Arora, Vikas Bhuria, Puja P. Hazari, Uma Pathak, Sweta Mathur, Bal G. Roy, Rajat Sandhir, Ravi Soni, Bilikere S. Dwarakanath & Anant N. Bhatt. (2018) Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice. Frontiers in Pharmacology 9.
Crossref
Crossref
Yaser Hosny Ali Elewa, Osamu Ichii, Kensuke Takada, Teppei Nakamura, Md. Abdul Masum & Yasuhiro Kon. (2018) Histopathological Correlations between Mediastinal Fat-Associated Lymphoid Clusters and the Development of Lung Inflammation and Fibrosis following Bleomycin Administration in Mice. Frontiers in Immunology 9.
Crossref
Crossref
Ju Kuang, Min Xie & Xiaolin Wei. (2018) The NALP3 inflammasome is required for collagen synthesis via the NF‑κB pathway. International Journal of Molecular Medicine.
Crossref
Crossref
F. Jessop, K.L. Trout, A. Holian & C. Migliaccio. 2018. Comprehensive Toxicology. Comprehensive Toxicology
94
114
.
Isabella Cattani-Cavalieri, Adriane Graça Reis, Emanuel Kennedy-Feitosa, Vanessa Pinho-Ribeiro, Manuella Lanzetti, Lycia Brito Gitirana, Bruna Romana-Souza, Luis Cristóvão Porto & Samuel Santos Valença. (2017) Pulmonary Emphysema Cross-Linking with Pulmonary Fibrosis and Vice Versa: a Non-usual Experimental Intervention with Elastase and Bleomycin. Inflammation 40:5, pages 1487-1496.
Crossref
Crossref
Michael F. Beers, Lars Knudsen, Yaniv Tomer, Julian Maronn, Ming Zhao, Matthias Ochs & Surafel Mulugeta. (2017) Aberrant lung remodeling in a mouse model of surfactant dysregulation induced by modulation of the Abca3 gene. Annals of Anatomy - Anatomischer Anzeiger 210, pages 135-146.
Crossref
Crossref
Samik BinduVinodkumar B. PillaiAbhinav KanwalSadhana SamantGökhan M. Mutlu, Eric Verdin, Nickolai Dulin & Mahesh P. Gupta. (2017) SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage. American Journal of Physiology-Lung Cellular and Molecular Physiology 312:1, pages L68-L78.
Crossref
Crossref
Toshiyuki Yamamoto. 2017. Animal Models for the Study of Human Disease. Animal Models for the Study of Human Disease
951
966
.
Chunmin Dong, Rafael Gongora, Meredith L. Sosulski, Fayong Luo & Cecilia G. Sanchez. (2016) Regulation of transforming growth factor-beta1 (TGF-β1)-induced pro-fibrotic activities by circadian clock gene BMAL1. Respiratory Research 17:1.
Crossref
Crossref
Kohei Togami, Sumio Chono & Hitoshi Tada. (2016) Alteration in Intrapulmonary Pharmacokinetics of Aerosolized Model Compounds Due to Disruption of the Alveolar Epithelial Barriers Following Bleomycin-Induced Pulmonary Fibrosis in Rats. Journal of Pharmaceutical Sciences 105:3, pages 1327-1334.
Crossref
Crossref
Gi-Su OhSu-Bin LeeAnjani KarnaHyung-Jin KimAiHua ShenArpana PanditSeungHoon LeeSei-Hoon YangHong-Seob So. (2016)
Increased Cellular NAD
+
Level through NQO1 Enzymatic Action Has Protective Effects on Bleomycin-Induced Lung Fibrosis in Mice
. Tuberculosis and Respiratory Diseases 79:4, pages 257.
Crossref
Crossref
Malgorzata Zagozda, Agnieszka Sarnecka, Zuzanna StaszczakHanna GałkowskaPiotr Andziak, Waldemar L. OlszewskiMarek Durlik. (2015)
Genetic Polymorphism and Messenger Ribonucleic Acid Concentrations of
TNFα
and
TGFβ
Genes in Patients with Chronic Lower Limb Infections
. Surgical Infections 16:6, pages 822-828.
Crossref
Crossref
Jae Chul Lee, Choong Ik Cha, Dong-Sik Kim & Soo Young Choe. (2015) Therapeutic Effects of Umbilical Cord Blood Derived Mesenchymal Stem Cell-Conditioned Medium on Pulmonary Arterial Hypertension in Rats. Journal of Pathology and Translational Medicine 49:6, pages 472-480.
Crossref
Crossref
Amit D. Kandhare, Subhash L. Bodhankar, Vishwaraman Mohan & Prasad A. Thakurdesai. (2015) Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-?B, Muc5ac, TNF-? and IL-1?. Chemico-Biological Interactions 237, pages 151-165.
Crossref
Crossref
Jamin A. WilloughbySr.Sr.. (2015) Predicting Respiratory Toxicity Using a Human 3D Airway (EpiAirway™) Model Combined with Multiple Parametric Analysis. Applied In Vitro Toxicology 1:1, pages 55-65.
Crossref
Crossref
Elizabeth F. Redente, Rebecca C. Keith, William Janssen, Peter M. Henson, Luis A. Ortiz, Gregory P. Downey, Donna L. Bratton & David W. H. Riches. (2014) Tumor Necrosis Factor-α Accelerates the Resolution of Established Pulmonary Fibrosis in Mice by Targeting Profibrotic Lung Macrophages. American Journal of Respiratory Cell and Molecular Biology 50:4, pages 825-837.
Crossref
Crossref
Viranuj Sueblinvong, Vern E. Kerchberger, Ramin Saghafi, Stephen T. Mills, Xian Fan & David M. Guidot. (2014) Chronic Alcohol Ingestion Primes the Lung for Bleomycin-Induced Fibrosis in Mice. Alcoholism: Clinical and Experimental Research 38:2, pages 336-343.
Crossref
Crossref
P. Shivshankar, H. Payan, C. Calhoun, S. Levine, R.O. WilliamsIII.III., J. Jagirdar, J.I. Peters & C. Jourdan Le Saux. (2014) Inhaled tacrolimus modulates pulmonary fibrosis without promoting inflammation in bleomycin-injured mice. Journal of Drug Delivery Science and Technology 24:5, pages 469-477.
Crossref
Crossref
Wei-ting Zhong, Yi-chun Wu, Xian-xing Xie, Xuan Zhou, Miao-miao Wei, Lanan-Wassy Soromou, Xin-xin Ci & Da-cheng Wang. (2013) Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice. Fitoterapia 90, pages 132-139.
Crossref
Crossref
Helen G. L. Gao, Paul W. Fisher, Alex G. Lambi, Christine K. Wade, Ann E. Barr-Gillespie, Steven N. Popoff & Mary F. Barbe. (2013) Increased Serum and Musculotendinous Fibrogenic Proteins following Persistent Low-Grade Inflammation in a Rat Model of Long-Term Upper Extremity Overuse. PLoS ONE 8:8, pages e71875.
Crossref
Crossref
Verena Aumiller, Nisha Balsara, Jochen Wilhelm, Andreas Günther & Melanie Königshoff. (2013) WNT/β-Catenin Signaling Induces IL-1β Expression by Alveolar Epithelial Cells in Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology 49:1, pages 96-104.
Crossref
Crossref
Devender S. Dhanda, Puneet Tyagi, Sidney S. Mirvish & Uday B. Kompella. (2013) Supercritical fluid technology based large porous celecoxib–PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose. Journal of Controlled Release 168:3, pages 239-250.
Crossref
Crossref
Ajit A. Kulkarni, Thomas H. Thatcher, Hsi-Min Hsiao, Keith C. Olsen, Robert Matthew Kottmann, Jason Morrissette, Terry W. Wright, Richard P. Phipps & Patricia J. Sime. (2013) The Triterpenoid CDDO-Me Inhibits Bleomycin-Induced Lung Inflammation and Fibrosis. PLoS ONE 8:5, pages e63798.
Crossref
Crossref
Ji Young Son, Song Yee Kim, Sang Ho Cho, Hyo Sub Shim, Ji-Ye Jung, Eun Young Kim, Ju Eun Lim, Byung Hoon Park, Young Ae Kang, Young Sam Kim, Se Kyu Kim, Joon Chang & Moo Suk Park. (2013) TGF-β1 T869C Polymorphism May Affect Susceptibility to Idiopathic Pulmonary Fibrosis and Disease Severity. Lung 191:2, pages 199-205.
Crossref
Crossref
Toshiyuki Yamamoto. 2013. Animal Models for the Study of Human Disease. Animal Models for the Study of Human Disease
1021
1035
.
Yaru Yang, Yan Huang, Cheng Huang, Xiongwen Lv, Liping Liu, Yuanyuan Wang & Jun Li. (2012)
Antifibrosis effects of triterpene acids of
Eriobotrya japonica
(Thunb.) Lindl. leaf in a rat model of bleomycin-induced pulmonary fibrosis
. Journal of Pharmacy and Pharmacology 64:12, pages 1751-1760.
Crossref
Crossref
Verónica S. Biaggio, Natalia R. Salvetti, María V. Pérez Chaca, Susana R. Valdez, Hugo H. Ortega, María S. Gimenez & Nidia N. Gomez. (2011) Alterations of the extracellular matrix of lung during zinc deficiency. British Journal of Nutrition 108:1, pages 62-70.
Crossref
Crossref
Jingrui Tian, Fang Yang & Huiqin Liu. (2012) TGF-Beta and CTGF Mediated Signal Transduction Pathway and Fibrosis. TGF-Beta and CTGF Mediated Signal Transduction Pathway and Fibrosis.
Daniel J. Schneider, Minghua Wu, Thuy T. Le, Seo‐Hee Cho, Michael B. Brenner, Michael R. Blackburn & Sandeep K. Agarwal. (2011) Cadherin‐11 contributes to pulmonary fibrosis: potential role in TGF‐β production and epithelial to mesenchymal transition. The FASEB Journal 26:2, pages 503-512.
Crossref
Crossref
Marianna M. Henry & Terry L. Noah. 2012. Kendig & Chernickâs Disorders of the Respiratory Tract in Children. Kendig & Chernickâs Disorders of the Respiratory Tract in Children
1026
1035
.
Peter Greaves. 2012. Histopathology of Preclinical Toxicity Studies. Histopathology of Preclinical Toxicity Studies
207
261
.
Sabina Sangaletti, Claudio Tripodo, Barbara Cappetti, Patrizia Casalini, Claudia Chiodoni, Silvia Piconese, Alessandra Santangelo, Mariella Parenza, Ivano Arioli, Silvia Miotti & Mario P. Colombo. (2011) SPARC Oppositely Regulates Inflammation and Fibrosis in Bleomycin-Induced Lung Damage. The American Journal of Pathology 179:6, pages 3000-3010.
Crossref
Crossref
Elizabeth F. Redente, Kristen M. Jacobsen, Joshua J. Solomon, Abigail R. Lara, Sarah FaubelRebecca C. Keith, Peter M. Henson, Gregory P. Downey & David W. H. Riches. (2011) Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 301:4, pages L510-L518.
Crossref
Crossref
Nathan Sandbo & Nickolai Dulin. (2011) Actin cytoskeleton in myofibroblast differentiation: Ultrastructure defining form and driving function. Translational Research 158:4, pages 181-196.
Crossref
Crossref
Keith C. Olsen, Ramil E. Sapinoro, R. M. Kottmann, Ajit A. Kulkarni, Siiri E. Iismaa, Gail V. W. Johnson, Thomas H. Thatcher, Richard P. Phipps & Patricia J. Sime. (2011) Transglutaminase 2 and Its Role in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 184:6, pages 699-707.
Crossref
Crossref
Remo C. Russo, Ana L. Alessandri, Cristiana C. Garcia, Barbara F. Cordeiro, Vanessa Pinho, Geovanni D. Cassali, Amanda E. I. Proudfoot & Mauro M. Teixeira. (2011) Therapeutic Effects of Evasin-1, a Chemokine Binding Protein, in Bleomycin-Induced Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology 45:1, pages 72-80.
Crossref
Crossref
Carly R. Perry, Melissa L. Burke, Deborah J. Stenzel, Donald P. McManus, Grant A. Ramm & Geoffrey N. Gobert. (2011) Differential Expression of Chemokine and Matrix Re-Modelling Genes Is Associated with Contrasting Schistosome-Induced Hepatopathology in Murine Models. PLoS Neglected Tropical Diseases 5:6, pages e1178.
Crossref
Crossref
Jian Gao, Yan Huang, Ping Li, Dujuan Xu, Jun Li, Yong Liu, Zhaogang Huang, Qiang Wu & Xu Shao. (2011) Antifibrosis effects of total glucosides of Danggui–Buxue–Tang in a rat model of bleomycin-induced pulmonary fibrosis. Journal of Ethnopharmacology 136:1, pages 21-26.
Crossref
Crossref
Min He, Ni Cheng, Wei-wei Gao, Meng Zhang, Yue-yun Zhang, Richard D Ye & Ming-wei Wang. (2011) Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury. Acta Pharmacologica Sinica 32:5, pages 601-610.
Crossref
Crossref
Woon Yong Kwon, Gil Joon Suh, Kyung Su Kim & Young Ho Kwak. (2011) Niacin attenuates lung inflammation and improves survival during sepsis by downregulating the nuclear factor-κB pathway*. Critical Care Medicine 39:2, pages 328-334.
Crossref
Crossref
Antonio Brucato, Rolando Cimaz, Roberto Caporali, Véronique Ramoni & Jill Buyon. (2009) Pregnancy Outcomes in Patients with Autoimmune Diseases and Anti-Ro/SSA Antibodies. Clinical Reviews in Allergy & Immunology 40:1, pages 27-41.
Crossref
Crossref
Kuen-Daw Tsai, Shu-Mei Yang, Jen-Chih Lee, Ho-Yiu Wong, Chuen-Ming Shih, Ting-Hui Lin, Min-Jen Tseng & Wei Chen. (2011)
Panax notoginseng
Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
. Evidence-Based Complementary and Alternative Medicine 2011, pages 1-7.
Crossref
Crossref
Douglas Arenberg, Tracy R. Luckhardt, Shannon Carskadon, Liujian Zhao, Mohammad A. Amin & Alisa E. Koch. (2010) Macrophage Migration Inhibitory Factor Promotes Tumor Growth in the Context of Lung Injury and Repair. American Journal of Respiratory and Critical Care Medicine 182:8, pages 1030-1037.
Crossref
Crossref
Toshiyuki YAMAMOTO. (2010) Animal model of systemic sclerosis. The Journal of Dermatology 37:1, pages 26-41.
Crossref
Crossref
C.T. Migliaccio & A. Holian. 2010. Comprehensive Toxicology. Comprehensive Toxicology
93
113
.
Nathan Sandbo, Steven Kregel, Sebastien Taurin, Sangeeta Bhorade & Nickolai O. Dulin. (2009) Critical Role of Serum Response Factor in Pulmonary Myofibroblast Differentiation Induced by TGF-β. American Journal of Respiratory Cell and Molecular Biology 41:3, pages 332-338.
Crossref
Crossref
Deborah E. Sullivan, MaryBeth Ferris, Hong Nguyen, Elizabeth Abboud & Arnold R. Brody. (2009)
TNF‐α induces TGF‐β
1
expression in lung fibroblasts at the transcriptional level
via
AP‐1 activation
. Journal of Cellular and Molecular Medicine 13:8b, pages 1866-1876.
Crossref
Crossref
Deborah E. Sullivan, MaryBeth Ferris, Hong Nguyen, Elizabeth Abboud & Arnold R. Brody. (2009)
TNF-α induces TGF-β
1
expression in lung fibroblasts at the transcriptional level
via
AP-1 activation
. Journal of Cellular and Molecular Medicine 13:8b, pages 1866-1876.
Crossref
Crossref
Handan MERT, Ibrahim YORUK, Ali ERTEKIN, Semiha DEDE, Yeter DEGER, Fatmagul YUR & Nihat MERT. (2009) Vitamin Levels in Lung Tissue of Rats with Bleomycin Induced Pulmonary Fibrosis. Journal of Nutritional Science and Vitaminology Journal of Nutritional Science and Vitaminology 55:2, pages 186-190.
Crossref
Crossref
Hisashi Oku, Toshikatsu Shimizu, Tomoji Kawabata, Morio Nagira, Ichiro Hikita, Azumi Ueyama, Shuuichi Matsushima, Mikinori Torii & Akinori Arimura. (2008) Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. European Journal of Pharmacology 590:1-3, pages 400-408.
Crossref
Crossref
Srinivasan Kalayarasan, Narayanan Sriram & Ganapasam Sudhandiran. (2008) Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: Critical role of iNOS, NF-?B, TNF-? and IL-1?. Life Sciences 82:23-24, pages 1142-1153.
Crossref
Crossref
Antje Moeller, Kjetil Ask, David Warburton, Jack Gauldie & Martin Kolb. (2008) The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?. The International Journal of Biochemistry & Cell Biology 40:3, pages 362-382.
Crossref
Crossref
Sonia B. JakowlewPatricia J. Sime, R. Matthew Kottmann, Heather F. Lakatos & Thomas H. Thatcher. 2008. Transforming Growth Factor-β in Cancer Therapy, Volume I. Transforming Growth Factor-β in Cancer Therapy, Volume I
629
647
.
Sonia B. JakowlewMasahito Ebina. 2008. Transforming Growth Factor-β in Cancer Therapy, Volume I. Transforming Growth Factor-β in Cancer Therapy, Volume I
569
580
.
Anna Serrano-Mollar, Maria Nacher, Gemma Gay-Jordi, Daniel Closa, Antoni Xaubet & Oriol Bulbena. (2007) Intratracheal Transplantation of Alveolar Type II Cells Reverses Bleomycin-induced Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine 176:12, pages 1261-1268.
Crossref
Crossref
Pamela Gasse, Caroline Mary, Isabelle Guenon, Nicolas Noulin, Sabine Charron, Silvia Schnyder-Candrian, Bruno Schnyder, Shizuo Akira, Valérie F.J. Quesniaux, Vincent Lagente, Bernhard Ryffel & Isabelle Couillin. (2007) IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. Journal of Clinical Investigation.
Crossref
Crossref
Luis A. OrtizMaria DuTreil, Cheryl FattmanAmitabh C. Pandey, German TorresKristina GoDonald G. Phinney. (2007) Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proceedings of the National Academy of Sciences 104:26, pages 11002-11007.
Crossref
Crossref
Ferah Armutcu, Mehmet ?abuk, Ahmet Gurel, Hulusi Atmaca & Levent Kart. (2007) Caffeic acid phenethyl ester and vitamin E moderates IL-1? and IL-6 in bleomycin-induced pulmonary fibrosis in rats. Pesticide Biochemistry and Physiology 88:2, pages 209-212.
Crossref
Crossref
Peter M. Izmirly, Tania L. Rivera & Jill P. Buyon. (2007) Neonatal Lupus Syndromes. Rheumatic Disease Clinics of North America 33:2, pages 267-285.
Crossref
Crossref
Berran Yucesoy & Michael I. Luster. (2007) Genetic susceptibility in pneumoconiosis. Toxicology Letters 168:3, pages 249-254.
Crossref
Crossref
Toshihiro Asai, Yasushi Ohno, Shinya Minatoguchi, Norihiko Funaguchi, Hideyuki Yuhgetsu, Masahiro Sawada, Genzou Takemura, A Komada, Takako Fujiwara & Hisayoshi Fujiwara. (2007) THE SPECIFIC FREE RADICAL SCAVENGER EDARAVONE SUPPRESSES BLEOMYCIN-INDUCED ACUTE PULMONARY INJURY IN RABBITS. Clinical and Experimental Pharmacology and Physiology 34:1-2, pages 22-26.
Crossref
Crossref
Peter Greaves. 2007. Histopathology of Preclinical Toxicity Studies. Histopathology of Preclinical Toxicity Studies
215
269
.
Nikos Oikonomou, Vaggelis Harokopos, Jonathan Zalevsky, Christos Valavanis, Anastasia Kotanidou, David E. Szymkowski, George Kollias & Vassilis Aidinis. (2006) Soluble TNF Mediates the Transition from Pulmonary Inflammation to Fibrosis. PLoS ONE 1:1, pages e108.
Crossref
Crossref
Arnold Brody & Deborah Sullivan. 2006. Particle Toxicology. Particle Toxicology
227
244
.
Michael Luster & Berran Yucesoy. 2006. Cytokine Gene Polymorphisms in Multifactorial Conditions. Cytokine Gene Polymorphisms in Multifactorial Conditions
351
362
.
George J. Brewer, Robert Dick, Chunhua Zeng & Guoqing Hou. (2006) The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model. Journal of Inorganic Biochemistry 100:5-6, pages 927-930.
Crossref
Crossref
Fangping Chen, Likun Gong, Ling Zhang, Hui Wang, Xinming Qi, Xiongfei Wu, Ying Xiao, Yan Cai, Linlin Liu, Xianghong Li & J. Ren. (2006) Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats. European Journal of Pharmacology 536:3, pages 287-295.
Crossref
Crossref
Siva Kanangat, Arnold E. Postlethwaite, Gloria C. Higgins & Karen A. Hasty. (2006) Novel Functions of Intracellular IL-1ra in Human Dermal Fibroblasts: Implications in the Pathogenesis of Fibrosis. Journal of Investigative Dermatology 126:4, pages 756-765.
Crossref
Crossref
Toshiyuki Yamamoto. (2006) The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?. Archives of Dermatological Research 297:8, pages 333-344.
Crossref
Crossref
Marianna M. Henry & Terry L. Noah. 2006. Kendig's Disorders of the Respiratory Tract in Children. Kendig's Disorders of the Respiratory Tract in Children
1000
1013
.
François Huaux. 2005. Inhalation Toxicology, Second Edition. Inhalation Toxicology, Second Edition
307
333
.
Tetsu Kobayashi, Xiangde Liu, Hui Jung Kim, Tadashi Kohyama, Fu-Qiang Wen, Shinji Abe, Qiuhong Fang, Yun Kui Zhu, John R Spurzem, Peter Bitterman & Stephen I Rennard. (2005) TGF-β1 and serum both stimulate contraction but differentially affect apoptosis in 3D collagen gels. Respiratory Research 6:1.
Crossref
Crossref
William E. Lawson, Vasiliy V. Polosukhin, Georgios T. Stathopoulos, Ornella Zoia, Wei Han, Kirk B. Lane, Bo Li, Edwin F. Donnelly, George E. Holburn, Kenneth G. Lewis, Robert D. Collins, William M. Hull, Stephan W. Glasser, Jeffrey A. Whitsett & Timothy S. Blackwell. (2005) Increased and Prolonged Pulmonary Fibrosis in Surfactant Protein C-Deficient Mice Following Intratracheal Bleomycin. The American Journal of Pathology 167:5, pages 1267-1277.
Crossref
Crossref
Ji Hyung Kim, Hye Young Kim, Sanghee Kim, Jin-Haeng Chung, Weon Seo Park & Doo Hyun Chung. (2005) Natural Killer T (NKT) Cells Attenuate Bleomycin-Induced Pulmonary Fibrosis by Producing Interferon-γ. The American Journal of Pathology 167:5, pages 1231-1241.
Crossref
Crossref
Fumiaki AokiMasahiko KurabayashiYoshihisa HasegawaItaru Kojima. (2005) Attenuation of Bleomycin-induced Pulmonary Fibrosis by Follistatin. American Journal of Respiratory and Critical Care Medicine 172:6, pages 713-720.
Crossref
Crossref
George J. Brewer. (2005) Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug Discovery Today 10:16, pages 1103-1109.
Crossref
Crossref
Jill P. Buyon & Robert M. Clancy. (2005) Neonatal Lupus: Basic Research and Clinical Perspectives. Rheumatic Disease Clinics of North America 31:2, pages 299-313.
Crossref
Crossref
Paul Okunieff, Terri Cornelison, Marcelo Mester, Weimin Liu, Ivan Ding, Yuchyau Chen, Hong Zhang, Jacqueline P. Williams & Jacob Finkelstein. (2005) Mechanism and modification of gastrointestinal soft tissue response to radiation: Role of growth factors. International Journal of Radiation Oncology*Biology*Physics 62:1, pages 273-278.
Crossref
Crossref
William E. Lawson, Vasiliy V. Polosukhin, Ornella Zoia, Georgios T. Stathopoulos, Wei Han, David Plieth, James E. Loyd, Eric G. Neilson & Timothy S. Blackwell. (2005) Characterization of Fibroblast-specific Protein 1 in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 171:8, pages 899-907.
Crossref
Crossref
Azza El–Medany, Hanan H. Hagar, Mahmoud Moursi, Raeesa At Muhammed, Fatma I. El-Rakhawy & Gamila El-Medany. (2005) Attenuation of bleomycin-induced lung fibrosis in rats by mesna. European Journal of Pharmacology 509:1, pages 61-70.
Crossref
Crossref
Jill P. Buyon & Robert M. Clancy. (2005) Autoantibody-associated congenital heart block: TGF? and the road to scar. Autoimmunity Reviews 4:1, pages 1-7.
Crossref
Crossref
Mohammed Arras, Jamila Louahed, Jean-Fran?ois Heilier, Monique Delos, Frank Brombacher, Jean-Christophe Renauld, Dominique Lison & Fran?ois Huaux. (2005) IL-9 Protects against Bleomycin-Induced Lung Injury. The American Journal of Pathology 166:1, pages 107-115.
Crossref
Crossref
Eleonora Cavarra, Fabio Carraro, Silvia Fineschi, Antonella Naldini, Barbara Bartalesi, Annalisa Pucci & Giuseppe Lungarella. (2004) Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs. American Journal of Physiology-Lung Cellular and Molecular Physiology 287:6, pages L1186-L1192.
Crossref
Crossref
Kevin K. Brown & Ganesh Raghu. (2004) Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects. Clinics in Chest Medicine 25:4, pages 759-772.
Crossref
Crossref
Robert M. Clancy & Jill P. Buyon. (2004) Autoimmune-associated congenital heart block: Dissecting the cascade from immunologic insult to relentless fibrosis. The Anatomical Record 280A:2, pages 1027-1035.
Crossref
Crossref
J P Buyon, A Rupel & R M Clancy. (2016) Neonatal lupus syndromes. Lupus 13:9, pages 705-712.
Crossref
Crossref
Fred K. Askari, Robert Dick, Maria Mao & George J. Brewer. (2016) Tetrathiomolybdate Therapy Protects Against Concanavalin a and Carbon Tetrachloride Hepatic Damage in Mice. Experimental Biology and Medicine 229:8, pages 857-863.
Crossref
Crossref
Luc E. Gosselin & Daniel A. Martinez. (2004) Impact of TNF‐α Blockade on TGF‐β1 and type I collagen mRNA expression in dystrophic muscle. Muscle & Nerve 30:2, pages 244-246.
Crossref
Crossref
Ulrike Bartram & Christian P. Speer. (2004) The Role of Transforming Growth Factor β in Lung Development and Disease. Chest 125:2, pages 754-765.
Crossref
Crossref
A. Luttun & P. Carmeliet. 2004. Proteases and Their Inhibitors in Cancer Metastasis. Proteases and Their Inhibitors in Cancer Metastasis
1
22
.
Momen Wahidi, David Schwartz & Ganesh Raghu. 2003. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis
31
54
.
Kevin Brown & Marvin Schwarz. 2003. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis
699
732
.
Mehrnaz Gharaee-Kermani & Sem Phan. 2003. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis
507
561
.
Steven Kunkel, Nicholas Lukacs, Stephen Chensue & Cory Hogaboam. 2003. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis
303
320
.
Masaki Fujita, John M. Shannon, Osamu Morikawa, Jack Gauldie, Nobuyuki Hara & Robert J. Mason. (2003) Overexpression of Tumor Necrosis Factor-α Diminishes Pulmonary Fibrosis Induced by Bleomycin or Transforming Growth Factor-β. American Journal of Respiratory Cell and Molecular Biology 29:6, pages 669-676.
Crossref
Crossref
George J Brewer. (2003) Copper lowering therapy with tetrathiomolybdate produces antiangiogenic, anticancer, antifibrotic, and antiinflammatory effects. Seminars in Integrative Medicine 1:4, pages 181-190.
Crossref
Crossref
Yan Yang, Xiaoning Zhe, Sem H. Phan, Matt Ullenbruch & Lucia Schuger. (2003) Involvement of Serum Response Factor Isoforms in Myofibroblast Differentiation During Bleomycin-Induced Lung Injury. American Journal of Respiratory Cell and Molecular Biology 29:5, pages 583-590.
Crossref
Crossref
Robert M. Clancy, Chelsea B. Backer, Xiaoming Yin, Raj P. Kapur, Yair Molad & Jill P. Buyon. (2003) Cytokine Polymorphisms and Histologic Expression in Autopsy Studies: Contribution of TNF-α and TGF-β1 to the Pathogenesis of Autoimmune-Associated Congenital Heart Block. The Journal of Immunology 171:6, pages 3253-3261.
Crossref
Crossref
D. M. Brass, J. D. Savov, S. H. Gavett, N. Haykal-Coates & D. A. Schwartz. (2003) Subchronic endotoxin inhalation causes persistent airway disease. American Journal of Physiology-Lung Cellular and Molecular Physiology 285:3, pages L755-L761.
Crossref
Crossref
Luc E. Gosselin, Jacob E. Barkley, Melissa J. Spencer, Kathleen M. McCormick & Gaspar A. Farkas. (2003) Ventilatory dysfunction inmdx mice: Impact of tumor necrosis factor-alpha deletion. Muscle & Nerve 28:3, pages 336-343.
Crossref
Crossref
David W. Shimabukuro, Teiji Sawa & Michael A. Gropper. (2003) Injury and repair in lung and airways. Critical Care Medicine 31:Supplement, pages S524-S531.
Crossref
Crossref
Luis A. Ortiz, Frederica Gambelli, Christine McBride, Dina Gaupp, Melody Baddoo, Naftali Kaminski & Donald G. Phinney. (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proceedings of the National Academy of Sciences 100:14, pages 8407-8411.
Crossref
Crossref
George J. Brewer, Matthew R. Ullenbruch, Robert Dick, Leovigildo Olivarez & Sem H. Phan. (2003) Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice. Journal of Laboratory and Clinical Medicine 141:3, pages 210-216.
Crossref
Crossref
Peter D. Arkwright, Vera Pravica, Philip J. Geraghty, Maurice Super, A. Kevin Webb, Martin Schwarz & Ian V. Hutchinson. (2003) End-Organ Dysfunction in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine 167:3, pages 384-389.
Crossref
Crossref
Stephen Chensue, Cory Hogaboam & Akihiro Matsukawa. 2003. Chemokines in the Lung. Chemokines in the Lung
221
238
.
G. J. Brewer. (2007) Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation. Journal of Cellular and Molecular Medicine 7:1, pages 11-20.
Crossref
Crossref
Robert M Clancy & Jill P Buyon. 2003. The Hearth in Systemic Autoimmune Diseases. The Hearth in Systemic Autoimmune Diseases
53
73
.
Shri N. Giri. 2003. Taurine 5. Taurine 5
381
394
.
John A. Belperio, Maria Dy, Marie D. Burdick, Ying Y. Xue, Kewang Li, Jack A. Elias & Michael P. Keane. (2002) Interaction of IL-13 and C10 in the Pathogenesis of Bleomycin-Induced Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology 27:4, pages 419-427.
Crossref
Crossref
Jack Gauldie, Zhou Xing, Martin Kolb, Patricia Sime & David Warburton. 2002. Gene Therapy in Lung Disease. Gene Therapy in Lung Disease
171
191
.
Sushmita Ghosh, Tamra Mendoza, Luis A. Ortiz, Gary W. Hoyle, Cesar D. Fermin, Arnold R. Brody, Mitchell Friedman & Gilbert F. Morris. (2002) Bleomycin Sensitivity of Mice Expressing Dominant-Negative p53 in the Lung Epithelium. American Journal of Respiratory and Critical Care Medicine 166:6, pages 890-897.
Crossref
Crossref
S.N. Giri, I. Biring, T. Nguyen, Q. Wang & D.M. Hyde. (2002) Abrogation of bleomycin-induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice. Nitric Oxide 7:2, pages 109-118.
Crossref
Crossref
Mehmet Koc, Pinar Polat & Selami Suma. (2002) Effects of tamoxifen on pulmonary fibrosis after cobalt-60 radiotherapy in breast cancer patients. Radiotherapy and Oncology 64:2, pages 171-175.
Crossref
Crossref
Yoshinori Tanino, Hironi Makita, Kenji Miyamoto, Tomoko Betsuyaku, Yoshinori Ohtsuka, Jun Nishihira & Masaharu Nishimura. (2002) Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. American Journal of Physiology-Lung Cellular and Molecular Physiology 283:1, pages L156-L162.
Crossref
Crossref
Regina M. Day, Yuichiro j. Suzuki, Julie M. Lum, Alexander C. White & Barry L. Fanburg. (2002) Bleomycin upregulates expression of γ-glutamylcysteine synthetase in pulmonary artery endothelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 282:6, pages L1349-L1357.
Crossref
Crossref
Mohamed H. Daba, Abdel-Aziz H. Abdel-Aziz, Adel M. Moustafa, Abdulhakeem A. Al-Majed, Othman A. Al-Shabanah & Hassan A. El-Kashef. (2002) Effects of L-Carnitine and Ginkgo Biloba Extract (EG b 761) in Experimental Bleomycin-Induced Lung Fibrosis. Pharmacological Research 45:6, pages 461-467.
Crossref
Crossref
Russell P. Bowler, Mike Nicks, Karrie Warnick & James D. Crapo. (2002) Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 282:4, pages L719-L726.
Crossref
Crossref
Marlene Strayer, Rashmin C. Savani, Linda W. Gonzales, Aisha Zaman, Zheng Cui, Edina Veszelovszky, Emily Wood, Ye-Shih Ho & Philip L. Ballard. (2002) Human surfactant protein B promoter in transgenic mice: temporal, spatial, and stimulus-responsive regulation. American Journal of Physiology-Lung Cellular and Molecular Physiology 282:3, pages L394-L404.
Crossref
Crossref
Nobuhiro Ohtake, Youichiro Nakai, Masahiro Yamamoto, Atsushi Ishige, Hiroshi Sasaki, Kazunori Fukuda, Seiji Hayashi & Satoshi Hayakawa. (2002) The herbal medicine Shosaiko-to exerts different modulating effects on lung local immune responses among mouse strains. International Immunopharmacology 2:2-3, pages 357-366.
Crossref
Crossref
S Yara, K Kawakami, N Kudeken, M Tohyama, K Teruya, T Chinen, A Awaya & A Saito. (2001) FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice. Clinical and Experimental Immunology 124:1, pages 77-85.
Crossref
Crossref
MASANORI SUGIYAMA & TAKANORI KUMAGAI. (2002) Molecular and Structural Biology of Bleomycin and Its Resistance Determinants. Journal of Bioscience and Bioengineering 93:2, pages 105-116.
Crossref
Crossref
S. N. Giri, G. Gurujeyalakshmi & Y. Wang. 2002. Taurine 4. Taurine 4
545
561
.
Z. Pawlowski. (2007) Toxocariasis in humans: clinical expression and treatment dilemma. Journal of Helminthology 75:4, pages 299-305.
Crossref
Crossref
Florian LangPhilip Cohen. (2001) Regulation and Physiological Roles of Serum- and Glucocorticoid-Induced Protein Kinase Isoforms. Science's STKE 2001:108.
Crossref
Crossref
William H. Chung, Brian M. Bennett, William J. Racz, James F. Brien & Thomas E. Massey. (2001)
Induction of c-
jun
and TGF-β1 in Fischer 344 rats during amiodarone-induced pulmonary fibrosis
. American Journal of Physiology-Lung Cellular and Molecular Physiology 281:5, pages L1180-L1188.
Crossref
Crossref
Pinak S. Acharya & David A. Zisman. (2001) Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis. Clinical Pulmonary Medicine 8:6, pages 327-334.
Crossref
Crossref
S Fillon, S W?rntges, J Matskevitch, I Moschen, I Setiawan, N Gamper, Y.X Feng, C Stegen, B Friedrich, S Waldegger, S Br?er, C.A Wagner, S.M Huber, K Klingel, A Vereninov & F Lang. (2001) Serum- and glucocorticoid-dependent kinase, cell volume, and the regulation of epithelial transport. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 130:3, pages 367-376.
Crossref
Crossref
Stefan Sleijfer. (2001) Bleomycin-Induced Pneumonitis. Chest 120:2, pages 617-624.
Crossref
Crossref
Tokio Osaki, Kazunori Yoneda, Yukihiro Tatemoto, Tetsuya Yamamoto, Takeshi Yokoyama & Hideaki Enzan. (2008) Peplomycin, a bleomycin derivative, induces myofibroblasts in pulmonary fibrosis. International Journal of Experimental Pathology 82:4, pages 231-241.
Crossref
Crossref
Martin Kolb, Peter J. Margetts, Daniel C. Anthony, Fernando Pitossi & Jack Gauldie. (2001) Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. Journal of Clinical Investigation 107:12, pages 1529-1536.
Crossref
Crossref
Patricia J. Sime & Katherine M.A. O'Reilly. (2001) Fibrosis of the Lung and Other Tissues: New Concepts in Pathogenesis and Treatment. Clinical Immunology 99:3, pages 308-319.
Crossref
Crossref
Leanne M Sutherland, Yasmin S Edwards & Andrew W Murray. (2001) Alveolar type II cell apoptosis. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 129:1, pages 267-285.
Crossref
Crossref
Peter Thomsen & Christina Gretzer. (2001) Macrophage interactions with modified material surfaces. Current Opinion in Solid State and Materials Science 5:2-3, pages 163-176.
Crossref
Crossref
Fumiyuki Takahashi, Kazuhisa Takahashi, Tatsuma Okazaki, Kayo Maeda, Hiroki Ienaga, Masahiro Maeda, Shigeyuki Kon, Toshimitsu Uede & Yoshinosuke Fukuchi. (2001) Role of Osteopontin in the Pathogenesis of Bleomycin-Induced Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology 24:3, pages 264-271.
Crossref
Crossref
MARTIN KOLB, PETER J. MARGETTS, TOM GALT, PATRICIA J. SIME, ZHOU XING, MICHAEL SCHMIDT & JACK GAULDIE. (2001) Transient Transgene Expression of Decorin in the Lung Reduces the Fibrotic Response to Bleomycin. American Journal of Respiratory and Critical Care Medicine 163:3, pages 770-777.
Crossref
Crossref
Yuhchyau Chen, Philip Rubin, Jacky Williams, Eric Hernady, Therese Smudzin & Paul Okunieff. (2001) Circulating IL-6 as a predictor of radiation pneumonitis. International Journal of Radiation Oncology*Biology*Physics 49:3, pages 641-648.
Crossref
Crossref
J. Zhang-Hoover, A. Sutton, N. Van Rooijen & J. Stein-Streilein. (2000) A critical role for alveolar macrophages in elicitation of pulmonary immune fibrosis. Immunology 101:4, pages 501-511.
Crossref
Crossref
Qingjian Wang, Yingjin Wang, Dallas M Hyde, Philip J Gotwals, Roy R Lobb, Sarah T Ryan & Shri N Giri. (2000) Effect of antibody against integrin α4 on bleomycin-induced pulmonary fibrosis in mice. Biochemical Pharmacology 60:12, pages 1949-1958.
Crossref
Crossref
XIAO YE ZHANG, SANAE SHIMURA, TOHRU MASUDA, HIROKI SAITOH & KUNIO SHIRATO. (2000) Antisense Oligonucleotides to NF- κ B Improve Survival in Bleomycin-induced Pneumopathy of the Mouse. American Journal of Respiratory and Critical Care Medicine 162:4, pages 1561-1568.
Crossref
Crossref
J A LaskyA R Brody. (2000) Interstitial fibrosis and growth factors.. Environmental Health Perspectives 108:suppl 4, pages 751-762.
Crossref
Crossref
G. Gurujeyalakshmi, Yingjin Wang & Shri N. Giri. (2000) Suppression of Bleomycin-Induced Nitric Oxide Production in Mice by Taurine and Niacin. Nitric Oxide 4:4, pages 399-411.
Crossref
Crossref
Erwei Song, Nengtai Ouyang, Markus H?rbelt, Balazs Antus, Minghui Wang & Michael S. Exton. (2000) Influence of Alternatively and Classically Activated Macrophages on Fibrogenic Activities of Human Fibroblasts. Cellular Immunology 204:1, pages 19-28.
Crossref
Crossref
Nobuhiro Ohtake, Rie Suzuki, Haruyuki Daikuhara, Youichiro Nakai, Masahiro Yamamoto, Sakae Amagaya, Atsushi Ishige, Hiroshi Sasaki, Yasuhiro Komatsu, Kazunori Fukuda & Seiji Hayashi. (2000) Modulation of lung local immune responses by oral administration of a herbal medicine Sho-saiko-to. International Journal of Immunopharmacology 22:6, pages 419-430.
Crossref
Crossref
Peter Greaves. 2000. Histopathology of Preclinical Toxicity Studies. Histopathology of Preclinical Toxicity Studies
203
253
.
Steven L. Kunkel, Sem H. Phan, Nicholas W. Lukacs, Cory Hogaboam & Stephen W. Chensue. 2000. Inflammatory Processes: Molecular Mechanisms and Therapeutic Opportunities. Inflammatory Processes: Molecular Mechanisms and Therapeutic Opportunities
89
98
.
Hong-Yu Zhang & Sem H. Phan. (1999)
Inhibition of Myofibroblast Apoptosis by Transforming Growth Factor β
1
. American Journal of Respiratory Cell and Molecular Biology 21:6, pages 658-665.
Crossref
Crossref
Toshifumi Nagahori, Makoto Dohi, Kunio Matsumoto, Kazuko Saitoh, Zen-Ichiro Honda, Toshikazu Nakamura & Kazuhiko Yamamoto. (1999) Interferon- γ Upregulates the c-Met/Hepatocyte Growth Factor Receptor Expression in Alveolar Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology 21:4, pages 490-497.
Crossref
Crossref
Thomas P. StrandjordDavid K. Madtes, Daniel J. Weiss & E. Helene Sage. (1999) Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 277:3, pages L628-L635.
Crossref
Crossref
Abdunnabi Ahmed Rayes & Jos? Roberto Lambertucci. (1999) A associa??o entre a toxocar?ase humana e os abscessos piog?nicos. Revista da Sociedade Brasileira de Medicina Tropical 32:4, pages 425-438.
Crossref
Crossref
Toshiyuki Yamamoto, Sinsuke Takagawa, Ichiro Katayama & Kiyoshi Nishioka. (1999) Anti-sclerotic Effect of Transforming Growth Factor-? Antibody in a Mouse Model of Bleomycin-Induced Scleroderma. Clinical Immunology 92:1, pages 6-13.
Crossref
Crossref
Gary W. Hoyle, Jian Li, Jeffrey B. Finkelstein, Todd Eisenberg, Jing-Yao Liu, Joseph A. Lasky, Grace Athas, Gilbert F. Morris & Arnold R. Brody. (1999) Emphysematous Lesions, Inflammation, and Fibrosis in the Lungs of Transgenic Mice Overexpressing Platelet-Derived Growth Factor. The American Journal of Pathology 154:6, pages 1763-1775.
Crossref
Crossref
David K. Madtes, Andrew L. Elston, Robert C. Hackman, Ashley R. Dunn & Joan G. Clark. (1999) Transforming Growth Factor- α Deficiency Reduces Pulmonary Fibrosis in Transgenic Mice. American Journal of Respiratory Cell and Molecular Biology 20:5, pages 924-934.
Crossref
Crossref
Arti Shukla, Natalie Meisler & Kenneth R Cutroneo. (2002) Transforming growth factor‐β: crossroad of glucocorticoid and bleomycin regulation of collagen synthesis in lung fibroblasts. Wound Repair and Regeneration 7:3, pages 133-140.
Crossref
Crossref
David R. Brigstock. (1999) The Connective Tissue Growth Factor/Cysteine- Rich 61/Nephroblastoma Overexpressed (CCN) Family*. Endocrine Reviews 20:2, pages 189-206.
Crossref
Crossref
Luis A. Ortiz, Joseph Lasky, Giuseppe Lungarella, Eleonora Cavarra, Piero Martorana, William A. Banks, Jacques J. Peschon, Hans-Ludwig Schmidts, Arnold R. Brody & Mitchell Friedman. (1999) Upregulation of the p75 But Not the p55 TNF- α Receptor mRNA after Silica and Bleomycin Exposure and Protection from Lung Injury in Double Receptor Knockout Mice. American Journal of Respiratory Cell and Molecular Biology 20:4, pages 825-833.
Crossref
Crossref
Toshiyuki Yamamoto, Shinsuke Takagawa, Ichiro Katayama, Kenshi Yamazaki, Yoichiro Hamazaki, Hiroshi Shinkai & Kiyoshi Nishioka. (1999) Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking Scleroderma. Journal of Investigative Dermatology 112:4, pages 456-462.
Crossref
Crossref
J. Gauldie, P. J. Sime, Z. Xing, B. Marr & G. M. Tremblay. 1999. Tissue Repair and Fibrosis. Tissue Repair and Fibrosis
35
45
.
S. H. Phan, K. Zhang, H. Y. Zhang & M. Gharaee-Kermani. 1999. Tissue Repair and Fibrosis. Tissue Repair and Fibrosis
173
182
.
Luis A. Ortiz, Kryztof MorozJing-Yao LiuGary W. Hoyle, Timothy Hammond, Raymond F. Hamilton, Andrij Holian, William Banks, Arnold R. BrodyMitchell Friedman. (1998) Alveolar macrophage apoptosis and TNF-α, but not p53, expression correlate with murine response to bleomycin. American Journal of Physiology-Lung Cellular and Molecular Physiology 275:6, pages L1208-L1218.
Crossref
Crossref
Patricia J. Sime, Robert A. Marr, David Gauldie, Zhou Xing, Bryan R. Hewlett, Frank L. Graham & Jack Gauldie. (1998) Transfer of Tumor Necrosis Factor-? to Rat Lung Induces Severe Pulmonary Inflammation and Patchy Interstitial Fibrogenesis with Induction of Transforming Growth Factor-?1 and Myofibroblasts. The American Journal of Pathology 153:3, pages 825-832.
Crossref
Crossref
Joseph A. Lasky, Luis A. Ortiz, Boihoang Tonthat, Gary W. Hoyle, Miriam Corti, Grace Athas, Giuseppe Lungarella, Arnold Brody & Mitchell Friedman. (1998) Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 275:2, pages L365-L371.
Crossref
Crossref
Robert B. Low & Sheryl L. White. (1998) Lung smooth muscle differentiation. The International Journal of Biochemistry & Cell Biology 30:8, pages 869-883.
Crossref
Crossref
Displaying 200 of 240 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list